Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Other Non-Current Assets (2022 - 2023)

Historic Other Non-Current Assets for Lexeo Therapeutics (LXEO) over the last 2 years, with Q3 2023 value amounting to $3.3 million.

  • Lexeo Therapeutics' Other Non-Current Assets rose 9.23% to $3.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $3.3 million, marking a year-over-year increase of 9.23%. This contributed to the annual value of $3.3 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Lexeo Therapeutics reported Other Non-Current Assets of $3.3 million as of Q3 2023, which was up 9.23% from $3.3 million recorded in Q4 2022.
  • Over the past 5 years, Lexeo Therapeutics' Other Non-Current Assets peaked at $3.3 million during Q4 2022, and registered a low of $3.2 million during Q3 2022.